Detection and significance of occult axillary node metastases in patients with invasive breast cancer
- PMID: 213191
- DOI: 10.1002/1097-0142(197810)42:4<2025::aid-cncr2820420452>3.0.co;2-j
Detection and significance of occult axillary node metastases in patients with invasive breast cancer
Abstract
Blocks of axillary lymph nodes from 78 patients with invasive breast cancer, which after "routine" pathological examination were regarded as negative for metastases, were step-sectioned at 20 u intervals. Occult metastases were detected in 24% of the cases. A significant association between such metastases and a lack of or slight degree of an intraductal carcinomatous component of the dominant cancer was noted. There was no relationship between occult metastases and 15 other histopathological and 3 clinical features investigated, including an average 5 year survival rate. Similarly there was no correlation between any of the possible discriminants investigated in the 24% of patients who have died of their diseases or are living with recurrence regardless of the presence of occult metastases. Factors accounting for the lack of universal survival in patients with Stage I (and those with occult metastases that might be designated as stage 11/2) remain enigmatic. It is concluded that attempts to detect occult metastases by extending histopathological methods may be more academic than practical or therapeutically significant.
Similar articles
-
Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.Cancer. 2009 Apr 15;115(8):1605-12. doi: 10.1002/cncr.24173. Cancer. 2009. PMID: 19197997
-
Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.Breast J. 2004 May-Jun;10(3):174-80. doi: 10.1111/j.1075-122X.2004.21328.x. Breast J. 2004. PMID: 15125740
-
Detection and significance of occult metastases in node-negative breast cancer.Br J Surg. 1993 Apr;80(4):459-63. doi: 10.1002/bjs.1800800417. Br J Surg. 1993. PMID: 8388305
-
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022. J Surg Oncol. 2004. PMID: 14991881 Review.
-
[Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].Ned Tijdschr Geneeskd. 2004 Dec 4;148(49):2428-32. Ned Tijdschr Geneeskd. 2004. PMID: 15626306 Review. Dutch.
Cited by
-
Detection of cervical lymph node micrometastasis and isolated tumor cells in oral squamous cell carcinoma using immunohistochemistry and serial sectioning.J Oral Maxillofac Pathol. 2016 Sep-Dec;20(3):436-444. doi: 10.4103/0973-029X.190946. J Oral Maxillofac Pathol. 2016. PMID: 27721609 Free PMC article.
-
Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance.Br J Cancer. 1987 Mar;55(3):303-6. doi: 10.1038/bjc.1987.59. Br J Cancer. 1987. PMID: 3552017 Free PMC article.
-
Joint meeting of the British and European Associations for Cancer Research and the Royal Society of Medicine (Section of Oncology). November 3-5, 1986, London. Abstracts.Br J Cancer. 1987 Mar;55(3):331-49. doi: 10.1038/bjc.1987.65. Br J Cancer. 1987. PMID: 3567066 Free PMC article. No abstract available.
-
Detection of lymph node metastases in human colorectal cancer by using 5-aminolevulinic acid-induced protoporphyrin IX fluorescence with spectral unmixing.Int J Mol Sci. 2013 Nov 21;14(11):23140-52. doi: 10.3390/ijms141123140. Int J Mol Sci. 2013. PMID: 24284403 Free PMC article.
-
Predicting axillary lymph node metastases in breast carcinoma patients.Breast Cancer Res Treat. 1996;37(2):135-49. doi: 10.1007/BF01806495. Breast Cancer Res Treat. 1996. PMID: 8750581